1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
VSee Health, Inc.

VSee Health, Inc.

VSEEW
VSee Health, Inc.US flagNASDAQ Global Market
0.04
USD
- -
- -
1.03MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
7
6
6
10
15
9
Operating Margin (%)
3.44
-22.95
-30.99
-44.94
-65.55
-55.77
Depreciation Expense
- -
- -
- -
1
3
1
Net Income, GAAP
- -
-1
-4
-58
-15
-60
Effective Tax Rate (%)
27.98
- -
- -
- -
- -
- -
Profit Margin (%)
6.49
-13.11
-65.26
-553.69
-100.65
-674.2
Working Capital
- -
-2
-4
-16
-8
- -
LT Debt
- -
- -
- -
1
1
- -
Total Equity
1
- -
-4
- -
5
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
ST Debt
- -
LT Borrowings
- -
LT Finance Leases
- -
Preferred Equity and Hybrid Capital
- -
Shares Outstanding
- -
Market Capitalization
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Total Current Assets
- -
Cash, Cash Equivalents & STI
- -
Accounts Receivable, Net
- -
Inventories
- -
Total Current Liabilities
- -
Payables & Accruals
- -
ST Debt
- -
Deferred Revenue
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-29,591.39%
Free Cash Flow
- -
- -
-40.53%
Net Income, GAAP
- -
- -
-74.5%
Sales/Revenue/Turnover
- -
- -
40.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
3
4
- -
10
2025
- -
4
4
- -
15
2026
3
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Milton Chen
Full Time Employees
2
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
One Gateway Center Newton MA United States of America 02458
IPO Date
Dec 31, 2021
CIK
0001864531
Website
vseehealth.com
Similar Companies
MSP Recovery, Inc. (LIFW)
Kooth plc (KOO.L)
Opyl Limited (OPL.AX)
HealthStream, Inc. (HSTM)
GeneDx Holdings Corp. (WGS)
Natural Health Farm Holdings Inc. (NHEL)
Business
VSee Health, Inc. (NASDAQ:VSEE) provides telehealth software platforms and clinician services focused on virtual care delivery and remote patient monitoring for healthcare providers and enterprises in the United States. The company offers a suite of core products and services including VSee Clinic for customizable virtual waiting rooms and clinics; VSee Messenger, a HIPAA-compliant text and video collaboration app; VSee APIs for seamless integration with electronic health records and patient metrics; VSee Remote Patient Monitoring for proactive health management; VSee Telehealth Staffing solutions; and iDoc Telehealth for 24/7 remote physician teams specializing in neurointensive care, cardiac intensive care, stroke, brain trauma, and other acute neurological conditions, complemented by teleradiology, AI-powered telesitter and telenursing tools, revenue cycle management, scheduling, and telepresence robotics integration. Operating through subsidiaries VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc., VSee Health serves hospitals, health systems, and government clients with no-code/low-code building blocks for rapid deployment of digital health workflows. Founded in 2008 and headquartered at One Gateway Center, Suite 507, Newton, Massachusetts, the company recently achieved FedRAMP High authorization in October 2025 enabling expanded federal partnerships; activated two new hospitals and 21 of 34 in its network on the iDoc platform generating over $500,000 in projected annual revenue with seven more slated for Q1 2026; completed 100,000-plus radiology reads across 18 hospitals post-approval; reported Q2 2025 revenue of $3.4 million up 98% year-over-year; submitted proposals for $3 million in new critical care and teleradiology contracts; launched partnerships including AbundaLife for health record management and Ava Robotics for ICU telepresence; and initiated discussions for platform expansion into the Philippines.